Literature DB >> 19023528

Corticosteroid physiology and principles of therapy.

Priyanka Gupta1, Vijayalakshmi Bhatia.   

Abstract

The adrenal cortex secretes glucocorticoids (GC), mineralocorticoids (MC) and androgens. GC maintain homeostasis, MC regulate fluid and electrolyte balance and adrenal androgens contribute to development of secondary sexual characteristics. Pharmacologic GC therapy is frequently indicated in the pediatric age group. Besides having many important side effects, prolonged high dose systemic GC therapy has a suppressive effect on endogenous steroid production. Therefore, GC therapy should be withdrawn gradually and stopped based on assessment of hypothalamo-pituitary-adrenal (HPA) axis recovery. Patients with HPA axis suppression require physiological replacement of GC along with enhancement of doses during periods of stress. Due to its immunosuppressive effects, issues about safety and efficacy of live virus vaccines in patients receiving systemic high dose GC therapy must be borne in mind.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19023528     DOI: 10.1007/s12098-008-0208-1

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  14 in total

Review 1.  Technical report: congenital adrenal hyperplasia. Section on Endocrinology and Committee on Genetics.

Authors: 
Journal:  Pediatrics       Date:  2000-12       Impact factor: 7.124

Review 2.  Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society.

Authors:  Peter E Clayton; Walter L Miller; Sharon E Oberfield; E Martin Ritzén; Wolfgang G Sippell; Phyllis W Speiser
Journal:  Horm Res       Date:  2002

Review 3.  Congenital adrenal hyperplasia.

Authors:  Deborah P Merke; Stefan R Bornstein
Journal:  Lancet       Date:  2005 Jun 18-24       Impact factor: 79.321

4.  Editorial: glucocorticoid replacement--how much is enough?

Authors:  Barbara P Lukert
Journal:  J Clin Endocrinol Metab       Date:  2006-03       Impact factor: 5.958

5.  Cortisol production rate in childhood and adolescence.

Authors:  B L Linder; N V Esteban; A L Yergey; J C Winterer; D L Loriaux; F Cassorla
Journal:  J Pediatr       Date:  1990-12       Impact factor: 4.406

6.  Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis.

Authors:  J R Kerrigan; J D Veldhuis; S A Leyo; A Iranmanesh; A D Rogol
Journal:  J Clin Endocrinol Metab       Date:  1993-06       Impact factor: 5.958

7.  Time course of recovery of adrenal function in children treated for leukemia.

Authors:  E I Felner; M T Thompson; A F Ratliff; P C White; B A Dickson
Journal:  J Pediatr       Date:  2000-07       Impact factor: 4.406

8.  Prolonged hypocortisolemia in hydrocortisone replacement regimens in adrenocorticotrophic hormone deficiency.

Authors:  Ann M Maguire; Geoffrey R Ambler; Bin Moore; Mark McLean; Marina G Falleti; Christopher T Cowell
Journal:  Pediatrics       Date:  2007-06-18       Impact factor: 7.124

9.  Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry.

Authors:  N V Esteban; T Loughlin; A L Yergey; J K Zawadzki; J D Booth; J C Winterer; D L Loriaux
Journal:  J Clin Endocrinol Metab       Date:  1991-01       Impact factor: 5.958

10.  Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone.

Authors:  J Paton; E Jardine; E McNeill; S Beaton; P Galloway; D Young; M Donaldson
Journal:  Arch Dis Child       Date:  2006-03-23       Impact factor: 3.791

View more
  12 in total

1.  Preparation and evaluation of in - situ gels containing hydrocortisone for the treatment of aphthous ulcer.

Authors:  Sanjana A; Mohammed Gulzar Ahmed; Jaswanth Gowda Bh
Journal:  J Oral Biol Craniofac Res       Date:  2021-02-19

2.  [Oral glucocorticoids : Therapeutic use and treatment monitoring in inflammatory rheumatic diseases].

Authors:  D Freier; C Strehl; F Buttgereit
Journal:  Hautarzt       Date:  2020-02       Impact factor: 0.751

Review 3.  [Oral glucocorticoids : Therapeutic use and treatment monitoring in inflammatory rheumatic diseases].

Authors:  D Freier; C Strehl; F Buttgereit
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

Review 4.  Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes.

Authors:  Janine Alessi; Giovana B de Oliveira; Beatriz D Schaan; Gabriela H Telo
Journal:  Diabetol Metab Syndr       Date:  2020-09-07       Impact factor: 3.320

5.  Analysis of therapeutic effectiveness and adverse effects of long-term corticosteroids among leprosy patients with reactions: A retrospective cohort study.

Authors:  Joyce Novelyn Siagian; Sri Linuwih Menaldi
Journal:  SAGE Open Med       Date:  2022-04-19

6.  Formulation Design of Hydrocortisone Films for the Treatment of Aphthous Ulcers.

Authors:  Mohammed Gulzar Ahmed; Sanjana Adinarayana
Journal:  Turk J Pharm Sci       Date:  2019-07-10

7.  Post-cytokine-release Salt Wasting as Inverse Tumor Lysis Syndrome in a Non-cerebral Natural Killer-cell Neoplasm.

Authors:  Hirotsugu Ariizumi; Yosuke Sasaki; Hiroshi Harada; Yui Uto; Remi Azuma; Tomohide Isobe; Koji Kishimoto; Eisuke Shiozawa; Masafumi Takimoto; Nobuyuki Ohike; Hiraku Mori
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

8.  Adrenal Insufficiency in Children With Nephrotic Syndrome on Corticosteroid Treatment.

Authors:  Karmila Abu Bakar; Khairunnisa Khalil; Yam Ngo Lim; Yok Chin Yap; Mirunalini Appadurai; Sangeet Sidhu; Chee Sing Lai; Azriyanti Anuar Zaini; Nurshadia Samingan; Muhammad Yazid Jalaludin
Journal:  Front Pediatr       Date:  2020-04-15       Impact factor: 3.418

Review 9.  Systemic corticosteroids for acute otitis media in children.

Authors:  Respati W Ranakusuma; Yupitri Pitoyo; Eka D Safitri; Sarah Thorning; Elaine M Beller; Sudigdo Sastroasmoro; Chris B Del Mar
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15

10.  Collaboration in the presence of cerebral edema: The complications of steroids.

Authors:  Camille Schwarzrock
Journal:  Surg Neurol Int       Date:  2016-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.